Cited by 229Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorForensic Toxicology and Drug Analysis

The DOI matches its Crossref record.

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

Harris, Debra S., Baggott, Matthew, Mendelson, Jack H., Mendelson, John E., Jones, Reese T.·2002·Psychopharmacology

DOI 10.1007/s00213-002-1131-1

Open this paper in CoChat — free account

Abstract

Rationale 3,4-Methylenedioxymethamphetamine (MDMA) is a widely used phenethylamine. Reports have described the effects of MDMA in a controlled laboratory setting, but the full range of effects of MDMA in humans is still not completely characterized.Objectives To describe the physiological, subjective, and hormonal changes after single doses of MDMA in a laboratory setting and examine relationships between these effects.Methods Eight MDMA-experienced volunteers each received placebo, 0.5 mg/kg, and 1.5 mg/kg oral doses of MDMA in a double-blind crossover study.Results The 1.5 mg/kg dose (comparable to that typically used by most participants) produced significant subjective effects, peaking at about 2 h after dosing, including some effects commonly associated with stimulant drugs, hallucinogens, and entactogens. MDMA significantly increased plasma cortisol, prolactin, and dehydroepiandrosterone (DHEA) levels. Increase in plasma cortisol after the 1.5 mg/kg dose correlated with increased heart rate, rate-pressure product, and drug liking. Rise in DHEA correlated with euphoria.Conclusions A typically used dose of MDMA produced effects commonly associated with stimulants and hallucinogens. Subjects liked MDMA. Correlations between cortisol and DHEA levels and some physiological and psychological effects are consistent with animal data suggesting that hormones modulate some responses to drugs of abuse.

Integrity signals

Registry

Crossref · 10.1007/s00213-002-1131-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 101–200 of 229

Increased cortisol levels in hair of recent Ecstasy/MDMA users
Parrott, A. C., Sands, H., Jones, L. L., Clow, A., Evans, P. D., Downey, L. A., & Tobias Stalder, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.006 · Cited by 34
Neuroscience Informed Prolonged Exposure Practice: Increasing Efficiency and Efficacy Through Mechanisms
Stojek, M. M., McSweeney, L. B., & Rauch, S. A. M. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00281 · Cited by 37
Sensation Seeking, Attitudes Toward Drug Use, and Actual Use Among Adolescents: Testing a Model for Alcohol and Ecstacy Use
Peñacoba, C., González, J. L., Abellán, I. C., & López‐López, A. (2008) · Substance Use & Misuse · doi:10.1080/10826080802241151 · Cited by 34
MDMA, cortisol, and heightened stress in recreational ecstasy users
Parrott, A. C., Montgomery, C., Wetherell, M. A., Downey, L. A., Stough, C. K. K., & Scholey, A. B. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000060 · Cited by 35
Repeated psychological stress testing in stimulant-dependent patients
Harris, D. S., Reus, V. I., Wolkowitz, O. M., Mendelson, J. E., & Jones, R. T. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.012 · Cited by 34
Self-citation
Altering Cortisol Level does not Change the Pleasurable Effects of Methamphetamine in Humans
Harris, D. S., Reus, V. I., Wolkowitz, O. M., Mendelson, J. E., & Jones, R. T. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300223 · Cited by 32
Self-citation
MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor
Puxty, D. J., Ramaekers, J. G., de la Torre, R., Farré, M., Pizarro, N., Pujadas, M., & Kuypers, K. P. C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00455 · Cited by 32
Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?
Martins, S. S., Storr, C. L., Alexandre, P. K., & Chilcoat, H. D. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.10.006 · Cited by 30
In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.
Fantegrossi, W. E. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.16.1.1 · Cited by 30
Stimulants, ecstasy, and other ‘party drugs’
WINSTOCK, A. R., & Flechais, R. (2020) · doi:10.1093/med/9780198713005.003.0053 · Cited by 29
Toward a New Science of Psychedelic Social Psychology: The Effects of MDMA (Ecstasy) on Social Connection
Lyubomirsky, S. (2022) · Perspectives on Psychological Science · doi:10.1177/17456916211055369 · Cited by 34
Mephedrone and Alcohol Interactions in Humans
Papaseit, E., Pérez‐Mañá, C., Perna, E. B. D. S. F., Olesti, E., Mateus, J., Kuypers, K. P. C., Theunissen, E. L., Fonseca, F., Torrens, M., Ramaekers, J. G., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01588 · Cited by 28
Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users
Jones, L. L., Reed, P., & Parrott, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116653106 · Cited by 28
Analysis of ecstasy in oral fluid by ion mobility spectrometry and infrared spectroscopy after liquid–liquid extraction
Armenta, S., Garrigues, S., de la Guárdia, M., Brassier, J., Alcalà, M., & Blanco, M. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.01.036 · Cited by 27
Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes
Boxler, M. I., Streun, G. L., Liechti, M. E., Schmid, Y., Kræmer, T., & Steuer, A. E. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00438 · Cited by 24
The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine (“ecstasy”): A concurrent microdialysis and plasma analysis study
Murnane, K. S., Kimmel, H. L., Rice, K. C., & Howell, L. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.012 · Cited by 23
Inhibition of MDMA ‐induced increase in cortisol does not prevent acute impairment of verbal memory
Kuypers, K. P. C., de la Torre, R., Farré, M., Pujadas, M., & Ramaekers, J. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02196.x · Cited by 24
Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms
Fonseca, D. A., Ribeiro, D. M., Tapadas, M., & Cotrim, M. D. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174156 · Cited by 24
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodríguez, C. I., Kalin, N. H., & McDonald, W. M. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19104 · Cited by 28
Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction
Glavonic, E., Mitić, M., & Adžić, M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25017 · Cited by 21
Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users
Wetherell, M. A., & Montgomery, C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3325-0 · Cited by 21
Recent-onset ecstasy use: Association with deviant behaviors and psychiatric comorbidity.
Martins, S. S., Mazzotti, G., & Chilcoat, H. D. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.3.275 · Cited by 20
MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy
Sarmanlu, M., Kuypers, K. P. C., Vizeli, P., & Kvamme, T. L. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110843 · Cited by 21
Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’
Parrott, A. C. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000262 · Cited by 21
MDMA can increase cortisol levels by 800% in dance clubbers
Parrott, A. C., Lock, J. Z., Adnum, L., & Thome, J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112454231 · Cited by 19
Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis
Regan, A., Margolis, S., de Wit, H., & Lyubomirsky, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258849 · Cited by 21
Refinements to rodent head fixation and fluid/food control for neuroscience
Barkus, C., Bergmann, C., Branco, T., Carandini, M., Chadderton, P. T., Galiñanes, G. L., Gilmour, G., Huber, D., Huxter, J. R., Khan, A. G., et al. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109705 · Cited by 23
Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits
Downey, L. A., Sands, H., Jones, L., Clow, A., Evans, P. D., Tobias Stalder, A., & Parrott, A. C. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2474 · Cited by 17
Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’)
Aguilar, M. A., García-Pardo, M. P., & Parrott, A. C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146556 · Cited by 18
Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study
Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.016 · Cited by 17
Modulation of Gut Microbiome in Ecstasy/MDMA-Induced Behavioral and Biochemical Impairment in Rats and Potential of Post-Treatment with Anacyclus pyrethrum L. Aqueous Extract to Mitigate Adverse Effects
Baslam, A., Aitbaba, A., Hanchi, A. L., Tazart, Z., Aboufatima, R., Soraa, N., Ait-El-Mokhtar, M., Boussaa, S., Baslam, M., & Chait, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109086 · Cited by 19
Couple Therapy With MDMA—Proposed Pathways of Action
Wagner, A. C. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.733456 · Cited by 16
Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors
Ponzoni, L., Braida, D., & Sala, M. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4352-4 · Cited by 15
Apparent Transient Effects of Recent ???Ecstasy??? Use on Cognitive Performance and Extrapyramidal Signs in Human Subjects
Smith, R. M., Tivarus, M. E., Campbell, H., Hillier, A. J., & Beversdorf, D. Q. (2006) · Cognitive and Behavioral Neurology · doi:10.1097/01.wnn.0000213909.41901.cc · Cited by 15
The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice
Saadat, K. S., Elliott, J. M., Colado, M. I., & Green, A. R. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106058022 · Cited by 15
Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol
Lear, M. K., Smith, S. M., Pilecki, B. C., Stauffer, C. S., & Luoma, J. B. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1083354 · Cited by 15
Increased anxiety-related behavior in male and female adult rats following early and late adolescent exposure to 3,4-methylenedioxymethamphetamine (MDMA)
Kolyaduke, O. V., & Hughes, R. N. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.004 · Cited by 15
„Ecstasy” (MDMA): Pharmakologie, Toxikologie und Behandlung der akuten Intoxikation
Liechti, M. E. (2003) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2003-39975 · Cited by 14
MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy
Parrott, A. C., Moore, D. G., Turner, J. J., Goodwin, J. E., Min, M. O., & Singer, L. T. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2342 · Cited by 13
MDMA Impairs Response to Water Intake in Healthy Volunteers
Baggott, M. J., Garrison, K. J., Coyle, J., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. (2016) · Advances in Pharmacological Sciences · doi:10.1155/2016/2175896 · Cited by 13
Self-citation
Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs
Parrott, A. (2018) · Brain Sciences · doi:10.3390/brainsci8030043 · Cited by 17
Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
Kuypers, K. P. C., Perna, E. B. D. S. F., Dolder, P. C., Toennes, S. W., Theunissen, E. L., Mason, N. L., Hutten, N. R. P. W., & Ramaekers, J. G. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4931-7 · Cited by 15
MDMA to Treat PTSD in Adults
Latimer, D. R., Stocker, M. D., Sayers, K., Green, J., Kaye, A. M., Abd-Elsayed, A. A., Cornett, E. M., Kaye, A. D., Varrassi, G., Viswanath, O., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4414 · Cited by 12
MDMA does not alter responses to the Trier Social Stress Test in humans
Bershad, A. K., Miller, M. A., & de Wit, H. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4621-x · Cited by 13
Sleep, energy and self rated cognition across 7 nights following recreational ecstasy/MDMA use
Parrott, A. (2008) · Sleep and Hypnosis · Cited by 11
Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective
Sessa, B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0531-1 · Cited by 13
Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects
Parrott, A. C., Hayley, A. C., & Downey, L. A. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2594 · Cited by 10
3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition
Rizzo, F. R., Federici, M., & Mercuri, N. B. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.037 · Cited by 10
Enhancing Fear Extinction: Pharmacological Approaches
Ponomareva, O. Y., Fenster, R. J., & Ressler, K. J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_443 · Cited by 7
Ecstasy tablets: Rapid identification and determination of enantiomeric excess of MDMA
Fagan, P., Spálovská, D., Kuchař, M., Černohorský, T., Komorousová, L., Kocourková, L., & Setnička, V. (2021) · Forensic Chemistry · doi:10.1016/j.forc.2021.100381 · Cited by 8
Structural analysis of MDMA in solution by methods of chiroptical spectroscopy supported by DFT calculations
Fagan, P., Spálovská, D., Jurok, R., Kuchař, M., Schrenková, V., & Setnička, V. (2021) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2021.103255 · Cited by 8
A Systematic Review of the MDMA Model to Address Social Impairment in Autism
Chaliha, D. R., Mamo, J. C. L., Albrecht, M. A., Lam, V., Takechi, R., & Vaccarezza, M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210101130258 · Cited by 7
Development and initial validation of an MDMA/Ecstasy motives assessment
Sottile, J. E., Macia, K. S., Wickham, R. E., & Haug, N. A. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107494 · Cited by 7
Amphetamine toxicity in the emergency department
Smets, G.-J., Bronselaer, K., Munnynck, K. D., Feyter, K. D., de Voorde, W. V., & Sabbe, M. B. (2005) · European Journal of Emergency Medicine · doi:10.1097/00063110-200508000-00010 · Cited by 7
Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)
Ballesta, S., Reymond, G., Pozzobon, M., & Duhamel, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147136 · Cited by 8
Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting
Corey, V., Pisano, V. D., & Halpern, J. H. (2016) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000499 · Cited by 9
The METEMP protocol: Massed exposure therapy enhanced with MDMA for PTSD
Maples‐Keller, J. L., Dunlop, B. W., & ROTHBAUM, B. O. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101400 · Cited by 7
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys.
Berro, L. F., Shields, H., Odabas-Geldiay, M., Rothbaum, B. O., Andersen, M. L., & Howell, L. L. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000196 · Cited by 6
The History of MDMA
Passie, T. (2023) · doi:10.1093/oso/9780198867364.001.0001 · Cited by 5
MDMA (ecstasy) enhances loud noise‐induced morphofunctional alterations in heart and adrenal gland
Fulceri, F., Ferrucci, M., Lenzi, P., Soldani, P., Bartalucci, A., Paparelli, A., & Gesi, M. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20971 · Cited by 5
A Case Study of the METEMP Protocol: Massed Exposure Therapy Enhanced With 3,4-Methylenedioxymethamphetamine (MDMA) for Posttraumatic Stress Disorder
Maples‐Keller, J. L., & ROTHBAUM, B. O. (2025) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2025.02.001 · Cited by 4
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors.
Mancusi, G., Miuli, A., Santorelli, M., Cavallotto, C., Susini, O., Pernaci, G., Výborová, E., Rosa, I., D’Onofrio, A. M., Camardese, G., et al. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115046 · Cited by 4
Diffuse hair loss associated with hyperprolactinaemia: report of three cases
Ziai, M., Cifuentes, L., Grosber, M., McIntyre, M., Prucha, H., Ring, J., & Chen, W. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12407 · Cited by 4
MDMA – hopes and fears associated with therapeutic use in mental disorders
Kozera, K., Cichoń, L., Wilczyński, K. M., & Janas-Kozik, M. H. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2020.10.002 · Cited by 4
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) in adults
Žuljević, M. F., Viđak, M., Vukojević, J., Hren, D., & Peričić, T. P. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015345 · Cited by 5
Substance Use Disorders
Nocon, J. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386007-1.00015-5 · Cited by 5
Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders
El‐Mallakh, R. S., Halpern, J. H., & Abraham, H. D. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch76 · Cited by 4
Neurobiology of Posttraumatic Stress Disorder: Circuits, Genomics, and Treatment
Beatty, Z. G., Kearney, M. G., Ponomareva, O. Y., & Ressler, K. J. (2026) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-102124-033854 · Cited by 5
La psychothérapie assistée par la MDMA dans la prise en charge du syndrome de stress post-traumatique
Fauvel, B., & Piolino, P. (2021) · Psychologie Française · doi:10.1016/j.psfr.2020.12.003 · Cited by 4
Bruxismo Secundario al Consumo Recreacional de Éxtasis: Revisión de la Literatura
López, D. M., Bugueno, I. M., Ormazábal, F. R., & Urrutia, C. G. (2015) · International journal of odontostomatology · doi:10.4067/s0718-381x2015000200006 · Cited by 3
Disorders relating to the use of ecstasy and other ‘party drugs’
WINSTOCK, A. R., & Schifano, F. (2012) · doi:10.1093/med/9780199696758.003.0066 · Cited by 3
Methylenedioxymethamphetamine (Ecstasy, MDMA)
Buckley, N. A. (2012) · Wiley eBooks · doi:10.1002/9781118105955.ch9 · Cited by 3
The effect of MDMA on anterior pituitary hormones: a secondary analysis of a randomized placebo-controlled trial
Atila, C., Camerin, S.-J., Liechti, M. E., & Christ‐Crain, M. (2025) · Endocrine Connections · doi:10.1530/ec-25-0254 · Cited by 2
Investigating the terminology used to describe Ecstasy
Turner, A., Gautam, L., Moore, C. M., & Cole, M. (2014) · Drugs and Alcohol Today · doi:10.1108/dat-07-2014-0029 · Cited by 2
A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA when Administered to Healthy Volunteers
Mt, P. (2009) · Cited by 2
MDMA in Psychiatry: Past, Present, and Future
Cooper, M., & Kim, A. (2018) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2018.130204 · Cited by 2
Macular hourglass-like hemorrhage after ecstasy use
Pagoulatos, D., Makri, Ο. E., Kapsala, Z. G., & Georgakopoulos, C. D. (2019) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2019.02.013 · Cited by 2
A novel Emotion Recognition Model for the Visually Impaired
Das, S. (2019) · IEEE International Conference for Convergence in Technology (I2CT) · doi:10.1109/i2ct45611.2019.9033801 · Cited by 2
Early Use in Psychotherapy
Passie, T. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198867364.003.0006 · Cited by 2
The pattern of memory and perceptual dysfunctions in recreational ecstasy users
Brown, J. (2005) · ANU Open Research (Australian National University) · doi:10.25911/5d7a2a76705b1 · Cited by 2
Drink spiking: an investigation of its occurrence and predictors of perpetration and victimisation
McPherson, B. A. (2011) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27575814 · Cited by 2
The Toxicity Debate
Passie, T. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198867364.003.0012 · Cited by 1
The Use of Psychedelics in Couples Therapy
Groveman, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-90006-8_2 · Cited by 1
Effect of 3,4 Methylendioxy Meth Amphetamine on hepatocyte and liver enzymes Wistar Rats
Fattahi, E., Forozanfar, M., & Haghighi, A. B. (2013) · مجله علمی دانشگاه علوم پزشکی گرگان · Cited by 1
Neurochemistry of Drug Abuse
Staley, J. K., & Cosgrove, K. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch6 · Cited by 1
A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA when Administered to Healthy Volunteers SPONSOR
Designee, S., Doblin, R., Mithoefer, M. C., Holland, J. A., & Mojeiko, V. (2009) · Cited by 1
Rise of a Recreational Drug
Passie, T. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198867364.003.0004 · Cited by 1
The Scheduling
Passie, T. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198867364.003.0008 · Cited by 1
MDMA as a Dance Drug
Passie, T. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198867364.003.0010 · Cited by 1
Substance Abuse among Residents of Gwagwalada Abuja, Nigeria
Umarudeen, A. M., Okoli, O. C., Mundi, J., Mitaire-Idonor, E., Moore, E. O., & Adah, E. U. (2023) · Archives of Current Research International · doi:10.9734/acri/2023/v23i7586 · Cited by 2
Neurobiology of 3,4-Methylenedioxymethamphetamine (MDMA, or ""Ecstasy"")
Baumann, M. H., & Rothman, R. B. (2007) · CRC Press eBooks · doi:10.1201/9781420054422.ch7 · Cited by 1
Amphetamine and Other Psychostimulants
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50008-8 · Cited by 1
MDMA and LSD
Parrott, A. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_13
Mass Spectral and Chromatographic Studies on a Series Of Regioisomers and Isobaric Derivatives Related to Methylenedioxymethamphetamines
Awad, T. (2006)
Az ecstasy hatása a kognitív funkciókra
Pázmány, P., Petschner, P., Ádori, C., Kirilly, E., Andó, R. D., Balogh, B., Gyöngyösi, N., & Bagdy, G. (2013) · Repository of the Academy's Library (Library of the Hungarian Academy of Sciences)
Acute, Repeated-Dose and Residual Effects of Amphetamines on Psychological Measures in Humans
Bajger, A. T. (2014) · doi:10.7916/d8wh2n4p
MDMA: Neurohormonal, Neurocognitive, and Psychobiological Aspects of Recreational Ecstasy
Parrott, A. C., Broadbear, J. H., Bruno, R., Degenhardt, L. J., Morefield, K., & Scholey, A. B. (2009) · The Open Addiction Journal · doi:10.2174/1874941000902010024
Estudios controlados en humanos de éxtasis
Farré, M., Roset, P. N., de la Torre, R., Poudevida, S., Abanades, S., Peiró, A. M., García, Y. Á., Pizarro, N., Segura, M., & Camı́, J. (2003) · Adicciones · doi:10.20882/adicciones.457
MDMA-assisted Psychotherapy in people with Posttraumatic Stress Disorder
Investigator, P., & Kotler, M. (2009)
(+/-)-3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") Investigator's Brochure
Jerome, L. (2007)

Authors: Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., & Jones, R. T.
Affiliations: University of California, San Francisco (US)
Harvard University (US)
ORCID: Baggott, Matthew
Mendelson, John E.
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2002-06-27
Volume: 162
Issue: 4
Pages: 396-405
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-002-1131-1
OpenAlex: W2085124531
Cited by: 229
References: 0
Citations by year: 2026: 2 · 2025: 7 · 2024: 3 · 2023: 26 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 10 · 2015: 14 · 2014: 15 · 2013: 10 · 2012: 14
FWCI: 8.39
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: Purdue University
National Institutes of Health (5p50da001696-18, 5m01rr000079-42)
University of California, San Francisco
National Institute on Drug Abuse (P01DA014528, DA-14528, DA-01696, DA 12393, P30DA012393, DA00053, DA 00064)
National Center for Research Resources (5-MO1-RR00079)
NIH Clinical Center
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: MDMA, ecstasy, subjective effects, plasma cortisol, prolactin, dehydroepiandrosterone, heart rate, rate-pressure product, drug liking, euphoria, entactogens, stimulants, hallucinogens, dose-response relationship
MeSH terms: Adult, Analysis of Variance, Cardiovascular Physiological Phenomena, Dehydroepiandrosterone, Dose-Response Relationship, Drug, Double-Blind Method, Female, Hallucinogens, Hormones, Humans, Hydrocortisone, Male, Prolactin, Psychometrics, Surveys and Questionnaires, Time Factors, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks